---
figid: PMC6460662__13046_2019_1094_Fig4_HTML
figlink: /pmc/articles/PMC6460662/figure/Fig4/
number: Fig. 4
caption: Mechanism of action of ALK inhibitors. ALK activates various signaling pathways
  involved in cell proliferation and survival, including the PI3K pathway, the RAS/MEK
  pathway and the JAK/STAT pathway. ALK inhibitors have similar mechanisms of action
  by binding to the ATP-binding site and blocking activation of ALK. Crizotinib was
  the first ALK inhibitor approved by the FDA but, unfortunately, resistance to Crizotinib
  commonly occurs due to mutations the ALK gene. Therefore, Ceritinib, Alectinib,
  Brigatinib and Lorlatinib were developed, and can be used for patients who are not
  responding to Crizotinib
pmcid: PMC6460662
papertitle: Clinical development of targeted and immune based anti-cancer therapies.
reftext: N. A. Seebacher, et al. J Exp Clin Cancer Res. 2019;38:156.
pmc_ranked_result_index: '67138'
pathway_score: 0.972648
filename: 13046_2019_1094_Fig4_HTML.jpg
figtitle: Mechanism of action of ALK inhibitors
year: '2019'
organisms: Homo sapiens
ndex: 52635f75-dec1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6460662__13046_2019_1094_Fig4_HTML.html
  '@type': Dataset
  description: Mechanism of action of ALK inhibitors. ALK activates various signaling
    pathways involved in cell proliferation and survival, including the PI3K pathway,
    the RAS/MEK pathway and the JAK/STAT pathway. ALK inhibitors have similar mechanisms
    of action by binding to the ATP-binding site and blocking activation of ALK. Crizotinib
    was the first ALK inhibitor approved by the FDA but, unfortunately, resistance
    to Crizotinib commonly occurs due to mutations the ALK gene. Therefore, Ceritinib,
    Alectinib, Brigatinib and Lorlatinib were developed, and can be used for patients
    who are not responding to Crizotinib
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK1
  - ALK
  - JAK2
  - PIK3CG
  - PIK3R3
  - PIK3CB
  - PIK3CD
  - MAP2K1
  - MAP2K2
  - JAK3
  - TYK2
  - AKT1
  - AKT2
  - PIK3CA
  - STAT6
  - KRAS
  - NRAS
  - STAT1
  - HRAS
  - AKT3
  - PIK3R4
  - PIK3R6
  - STAT2
  - STAT5B
  - STAT3
  - PIK3R5
  - STAT5A
  - STAT4
  - Cancer
  - Lung cancer
genes:
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: ALK
  symbol: ALK
  source: hgnc_symbol
  hgnc_symbol: ALK
  entrez: '238'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
